MARKET

ESALF

ESALF

Eisai Co Ltd
OTCPK
30.00
NaN%
Closed 09:30 01/02 EST
OPEN
--
PREV CLOSE
30.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
66.19
52 WEEK LOW
27.36
MARKET CAP
8.46B
P/E (TTM)
25.20
1D
5D
1M
3M
1Y
5Y
1D
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Seeking Alpha · 12/30/2025 13:57
Weekly Report: what happened at ESALF last week (1222-1226)?
Weekly Report · 12/29/2025 10:21
Weekly Report: what happened at ESALF last week (1215-1219)?
Weekly Report · 12/22/2025 10:21
Weekly Report: what happened at ESALF last week (1208-1212)?
Weekly Report · 12/15/2025 10:29
Biogen: Alzheimer's Disease Treatment Needs More Real-World Data
Seeking Alpha · 12/15/2025 03:22
Weekly Report: what happened at ESALF last week (1201-1205)?
Weekly Report · 12/08/2025 10:27
Alzheimer's Clinical Trial Results, Sadly Running True To Form
Seeking Alpha · 12/04/2025 11:30
Weekly Report: what happened at ESALF last week (1124-1128)?
Weekly Report · 12/01/2025 10:22
More
About ESALF
Eisai Co Ltd is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), Asia and Latin America (Korea, Taiwan, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Webull offers Eisai Co Ltd stock information, including OTCPK: ESALF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ESALF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ESALF stock methods without spending real money on the virtual paper trading platform.